Sarah Knerr
Assistant Professor, Health Systems and Population Health
Education
PhD University of Washington, 2015 (Health Services)MPH University of Washington, 2011 (Public Health Genetics)
BA Vassar College, 2007 (Biochemistry)
Contact Info
email: saknerr@uw.eduoffice: HRC 431
address:
University of Washington
3980 15th Ave NE
Seattle, WA 98195-1621
campus box: 351621
voice: 206-221-1755
Cancer prevention and control; translational genomics; stakeholder engagement; health and health care disparities
- HSERV 522
Health Program Evaluation
Reed AK, Kohn MJ, Stayman S, Cole AM, Ko CW, Konnick EQ, Swanson PE, Zhang Y, Knerr S. Patient navigation for hereditary colorectal cancer: Design of a randomized controlled trial to determine the effectiveness of pathways to genetic counseling. Contemp Clin Trials. 2022 May;116:106735. doi: 10.1016/j.cct.2022.106735. Epub 2022 Mar 21. PMID: 35331945
Angelo F, Veenstra D, Knerr S, Devine B. Prevalence and prediction of medical distrust in a diverse medical genomic research sample. Genet Med. 2022 Apr 6. pii: S1098-3600(22)00697-9. doi: 10.1016/j.gim.2022.03.007. [Epub ahead of print] PMID: 35384843
Muessig KR, Zepp JM, Keast E, Shuster EE, Reyes AA, Arnold B, Ingphakorn C, Gilmore MJ, Kauffman TL, Hunter JE, Knerr S, Feigelson HS, Goddard KAB. Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system. Hered Cancer Clin Pract. 2022 Feb 10;20(1):7. doi: 10.1186/s13053-022-00213-5. PMID: 35144679 PMCID: PMC8832647
Conley CC, Wernli KJ, Knerr S, Li T, Leppig K, Ehrlich K, Farrell D, Gao H, Bowles EJA, Graham AL, Luta G, Jayasekera J, Mandelblatt JS, Schwartz MD, O'Neill SC. Using Protection Motivation Theory to Predict Intentions for Breast Cancer Risk Management: Intervention Mechanisms from a Randomized Controlled Trial. J Cancer Educ. 2021 Nov 23. doi: 10.1007/s13187-021-02114-y. [Epub ahead of print] PMID: 34813048 PMCID: PMC9124715
Mittendorf KF, Knerr S, Kauffman TL, Lindberg NM, Anderson KP, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Zepp JM, Syngal S, Wilfond BS, Goddard KAB. Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities. JCO Precis Oncol. 2021 Nov 3;5. pii: PO.21.00233. doi: 10.1200/PO.21.00233. eCollection 2021. Review. PMID: 34778694 PMCID: PMC8585306
PubMed
DOI
Angelo F, Veenstra D, Knerr S, Devine B. Prevalence and prediction of medical distrust in a diverse medical genomic research sample. Genet Med. 2022 Apr 6. pii: S1098-3600(22)00697-9. doi: 10.1016/j.gim.2022.03.007. [Epub ahead of print] PMID: 35384843
PubMed
DOI
Muessig KR, Zepp JM, Keast E, Shuster EE, Reyes AA, Arnold B, Ingphakorn C, Gilmore MJ, Kauffman TL, Hunter JE, Knerr S, Feigelson HS, Goddard KAB. Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system. Hered Cancer Clin Pract. 2022 Feb 10;20(1):7. doi: 10.1186/s13053-022-00213-5. PMID: 35144679 PMCID: PMC8832647
PubMed
PubMed Central
DOI
Conley CC, Wernli KJ, Knerr S, Li T, Leppig K, Ehrlich K, Farrell D, Gao H, Bowles EJA, Graham AL, Luta G, Jayasekera J, Mandelblatt JS, Schwartz MD, O'Neill SC. Using Protection Motivation Theory to Predict Intentions for Breast Cancer Risk Management: Intervention Mechanisms from a Randomized Controlled Trial. J Cancer Educ. 2021 Nov 23. doi: 10.1007/s13187-021-02114-y. [Epub ahead of print] PMID: 34813048 PMCID: PMC9124715
PubMed
PubMed Central
DOI
Mittendorf KF, Knerr S, Kauffman TL, Lindberg NM, Anderson KP, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Zepp JM, Syngal S, Wilfond BS, Goddard KAB. Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities. JCO Precis Oncol. 2021 Nov 3;5. pii: PO.21.00233. doi: 10.1200/PO.21.00233. eCollection 2021. Review. PMID: 34778694 PMCID: PMC8585306
PubMed
PubMed Central
DOI
2019
Member, thesis committee for Solongo Sainkhuu
Evaluating Training Gaps Among Public Health Practitioners in Washington State
Applying Population Management Best Practices to Preventive Genomic Medicine
National Institutes of Health (NIH)PI: Knerr Dates: 4/1/2023 - 3/31/2028
Health Promotion and Disease Prevention Centers
Centers for Disease Control and Prevention (CDC)PI: Hannon Dates: 9/30/2022 - 9/29/2023
Optimizing Implementation in Cancer Control (OPTICC)
National Cancer Institute (NCI)PI: Weiner Dates: 9/1/2022 - 8/31/2023
Health Promotion and Disease Prevention Centers
Centers for Disease Control and Prevention (CDC)PI: Hannon Dates: 9/30/2021 - 9/29/2022
Optimizing Implementation in Cancer Control (OPTICC)
National Cancer Institute (NCI)PI: Weiner Dates: 9/1/2021 - 8/31/2022
eMERGE IV Northwest: A partnership to evaluate the use of genomic information in the health care of diverse participants
National Institutes of Health (NIH)PI: Jarvik Dates: 5/1/2021 - 4/30/2022
Health Promotion and Disease Prevention Research Centers
Centers for Disease Control and Prevention (CDC)PI: Hannon Dates: 9/30/2020 - 9/29/2021
Exome sequencing in Diverse Populations in Colorado & Oregon
Kaiser Foundation Research InstitutePI: Jarvik Dates: 6/1/2020 - 5/31/2022
Exome sequencing in Diverse Populations in Colorado & Oregon
Kaiser Permanente Center for Health ResearchPI: Jarvik Dates: 6/1/2020 - 5/31/2021
eMERGE IV Northwest: A partnership to evaluate the use of genomic information in the health care of diverse participants
National Institutes of Health (NIH)PI: Jarvik Dates: 4/1/2020 - 3/31/2025
Implementing the moon: Getting genomic testing to the public
National Institutes of Health (NIH)PI: Bowen Dates: 9/1/2019 - 8/31/2024
Population Management for Hereditary Cancer Prevention: Implementation, Effectiveness, and Acceptability Within A Learning Health System
National Institutes of Health (NIH)PI: Knerr Dates: 4/1/2019 - 3/31/2022